|
Replication-incompetent GM-CSF-expressing gene-modified allogeneic chronic myeloid leukemia cancer cell lines |
|---|---|
| Trade Name | Gvax Chronic Myeloid Leukemia |
| Orphan Indication | Chronic myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2010-04-30 00:00:00 |
| Sponsor | Aduro BioTech, Inc.;740 Heinz Avenue;Berkeley, California, 94710 |
Related Access Program
Pusan National University Hospital – Chronic Myeloid Leukemia
University of California, San Francisco – Chronic Myeloid Leukemia
Emory University – Chronic Myeloid Leukemia
Pusan National University Hospital – Chronic myeloid leukemia
University of California, San Francisco – Chronic myeloid leukemia
Pfizer – Chronic myeloid leukemia
Emory University – Chronic myeloid leukemia
